MDXG MIMEDX GROUP INC revenue, earnings and financials
For the quarter ended June 30, 2026, MIMEDX GROUP INC reported revenue of $64.4M (down 34.7% from a year earlier), net income of −$14.8M and diluted EPS of −$0.10; over the last four quarters revenue was $355M and net income $6.24M; for the fiscal year ended December 2025 revenue was $419M, up 20.0% on the year before.
MDXG annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $419M, gross profit $346M, operating income $63.9M, net income $48.6M (margin 11.6%), EPS $0.32
- Fiscal year ended Dec 2024: revenue $349M, gross profit $289M, operating income $58.9M, net income $42.4M (margin 12.2%), EPS $0.28
- Fiscal year ended Dec 2023: revenue $321M, gross profit $267M, operating income $37.1M, net income $58.2M (margin 18.1%), EPS $0.37
- Fiscal year ended Dec 2022: revenue $268M, gross profit $220M, operating income −$14.7M, net income −$30.2M (margin -11.3%), EPS −$0.33
- Fiscal year ended Dec 2021: revenue $242M, gross profit $202M, operating income −$7.05M, net income −$10.3M (margin -4.2%), EPS −$0.15
MDXG quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $64.4M (down 34.7% year over year), net income −$14.8M, EPS −$0.10
- Quarter ended Mar 31, 2026: revenue $59.0M (down 33.1% year over year), net income −$10.9M, EPS −$0.07
- Quarter ended Dec 31, 2025 (from the annual report): revenue $118M (up 27.1% year over year), net income $15.2M, EPS $0.10
- Quarter ended Sep 30, 2025: revenue $114M (up 35.3% year over year), net income $16.7M, EPS $0.11
- Quarter ended Jun 30, 2025: revenue $98.6M (up 13.1% year over year), net income $9.62M, EPS $0.06
- Quarter ended Mar 31, 2025: revenue $88.2M (up 4.1% year over year), net income $7.02M, EPS $0.05
- Quarter ended Dec 31, 2024 (from the annual report): revenue $92.9M (up 7.0% year over year), net income $7.44M, EPS $0.05
- Quarter ended Sep 30, 2024: revenue $84.1M (up 2.9% year over year), net income $8.10M, EPS $0.05
- Quarter ended Jun 30, 2024: revenue $87.2M (up 7.3% year over year), net income $17.6M, EPS $0.12
- Quarter ended Mar 31, 2024: revenue $84.7M (up 18.2% year over year), net income $9.26M, EPS $0.06
- Quarter ended Dec 31, 2023 (from the annual report): revenue $86.8M (up 16.7% year over year), net income $53.5M, EPS $0.36
- Quarter ended Sep 30, 2023: revenue $81.7M (up 20.7% year over year), net income $8.53M, EPS $0.06
- Quarter ended Jun 30, 2023: revenue $81.3M (up 21.5% year over year), net income $1.20M, EPS $0.01
- Quarter ended Mar 31, 2023: revenue $71.7M (up 21.7% year over year), net income −$4.98M, EPS −$0.06
- Quarter ended Dec 31, 2022 (from the annual report): revenue $74.4M (up 46.4% year over year), net income −$414K, EPS −$0.02
- Quarter ended Sep 30, 2022: revenue $67.7M (up 7.3% year over year), net income −$8.43M, EPS −$0.09
- Quarter ended Jun 30, 2022: revenue $66.9M (down 1.9% year over year), net income −$10.9M, EPS −$0.11
- Quarter ended Mar 31, 2022: revenue $58.9M (down 1.8% year over year), net income −$10.5M, EPS −$0.11
- Quarter ended Dec 31, 2021 (from the annual report): revenue $50.8M, net income $2.22M, EPS $0.01
- Quarter ended Sep 30, 2021: revenue $63.1M, net income −$2.34M, EPS −$0.04
MDXG cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $74.0M, share buybacks $0
- Fiscal year ended Dec 2024: operating cash flow $66.2M, share buybacks $0
- Fiscal year ended Dec 2023: operating cash flow $26.8M, share buybacks $9.52M
- Fiscal year ended Dec 2022: operating cash flow −$17.9M, share buybacks $0
- Fiscal year ended Dec 2021: operating cash flow −$1.98M, share buybacks $0
MDXG balance sheet
- Jun 30, 2026: cash $136M, total assets $281M, total liabilities $65.0M, shareholders' equity $216M, long-term debt $15.7M
- Mar 31, 2026: cash $160M, total assets $309M, total liabilities $65.7M, shareholders' equity $243M, long-term debt $16.1M
- Dec 31, 2025: cash $166M, total assets $343M, total liabilities $86.1M, shareholders' equity $257M, long-term debt $16.5M
- Sep 30, 2025: cash $142M, total assets $319M, total liabilities $80.0M, shareholders' equity $239M, long-term debt $16.8M
- Jun 30, 2025: cash $119M, total assets $291M, total liabilities $74.5M, shareholders' equity $217M, long-term debt $17.2M
- Mar 31, 2025: cash $106M, total assets $270M, total liabilities $67.6M, shareholders' equity $203M, long-term debt $17.5M
- Dec 31, 2024: cash $104M, total assets $264M, total liabilities $70.8M, shareholders' equity $193M, long-term debt $17.8M
- Sep 30, 2024: cash $88.8M, total assets $244M, total liabilities $62.9M, shareholders' equity $181M, long-term debt $18.0M
What is MDXG's revenue?
MIMEDX GROUP INC reported $355M of revenue over its last four quarters, through June 30, 2026.
Is MDXG profitable?
Yes. MIMEDX GROUP INC earned $6.24M over the last four quarters.
What is MDXG's EPS?
Diluted earnings per share over the last four quarters were $0.04; −$0.10 in the latest quarter.